INITIAL 13G

Company

Beam Therapeutics Inc.

Filed

July 14, 2022

Accession Number

0000908834-22-000110

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →